Close

Cowen Reiterates Outperform on Ironwood Pharma (IRWD) Following IW-1973 Data

June 25, 2018 8:03 AM EDT
Get Alerts IRWD Hot Sheet
Price: $8.71 +1.04%

Rating Summary:
    14 Buy, 11 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE

Cowen reiterated an Outperform rating and $20.00 price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) following the company's presentation of additional data from its Phase IIa study testing IW-1973 in HFpEF.

IW-1973 led to improvements in insulin resistance as shown by Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) score decline by an average of 36% during the 14-day trial period, compared to 13% in patients taking a placebo.

For an analyst ratings summary and ratings history on Ironwood Pharmaceuticals click here. For more ratings news on Ironwood Pharmaceuticals click here.

Shares of Ironwood Pharmaceuticals closed at $19.34 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Cowen & Co